Skip to main content

Table 1 Clinical characteristics of patient groups at baseline

From: The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients

Analyte

Placebo (n = 87)

1 mg (n = 170)

Folate

33.7 (11.6)

35.6 (11.9)

B6

97.2 (7.3)

132.2 (12.1)

B12

266.1 (94.3)

289.3 (104.4)

Hcy

9.5 (2.6)

9.4 (2.8)

High Disability

79 (91 %)

134 (79 %)

High Frequency

56 (64 %)

109 (64 %)

High Severity

43 (49 %)

73(43 %)